Efficacy of Xinbao pill on chronic heart failure: Study protocol of a multicenter, randomized, double-blind, placebo-controlled trial

Introduction: Chronic heart failure (CHF) is a common cardiovascular disease. In China, Xinbao pill (XBP) is widely used as an adjuvant therapy for CHF. However, there is still a lack of high-quality clinical evidence. We designed this multicenter, randomized, double-blind, placebo-controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanping, Li, Jiahua, Yan, Jiaqi, Wang, Yulin, Cheng, Yuanyuan, Liu, Zhongqiu, Wang, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640989/
https://www.ncbi.nlm.nih.gov/pubmed/36386125
http://dx.doi.org/10.3389/fphar.2022.1058799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640989/
https://www.ncbi.nlm.nih.gov/pubmed/36386125
http://dx.doi.org/10.3389/fphar.2022.1058799

Ejemplares similares